Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer by Mike Wenzel, Thomas Steuber, Carolin Siech, Maximilian Kriegmair, Benedikt Hoeh, Derya Tilki, Axel S. Merseburger, Felix K.H. Chun, Philipp Mandel

Get full text